OTC Markets OTCQB - Delayed Quote USD
Nymox Pharmaceutical Corporation (NYMXF)
0.1178
0.0000
(0.00%)
At close: April 23 at 4:00:00 PM EDT
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
627
1,625
1,443
4,343
Total Liabilities Net Minority Interest
3,800
2,107
1,949
2,198
Total Equity Gross Minority Interest
-3,173
-482
-506
2,145
Total Capitalization
-3,173
-482
-506
2,145
Common Stock Equity
-3,173
-482
-506
2,145
Capital Lease Obligations
--
173
391
426
Net Tangible Assets
-3,173
-482
-506
2,145
Working Capital
-3,175
-650
-749
1,928
Invested Capital
-3,173
-482
-506
2,145
Tangible Book Value
-3,173
-482
-506
2,145
Total Debt
--
173
391
426
Share Issued
93,540.1400
90,515.1400
85,545.8750
77,961.1510
Ordinary Shares Number
93,540.1400
90,515.1400
85,545.8750
77,961.1510
12/31/2020 - 11/26/1997
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MDNAF Medicenna Therapeutics Corp.
0.7590
-0.78%
NGENF NervGen Pharma Corp.
2.1300
-0.93%
LIXTW Lixte Biotechnology Holdings, Inc.
0.0300
0.00%
BETRF BetterLife Pharma Inc.
0.0680
0.00%
IMTXW Immatics N.V.
0.0184
+47.20%
ATNFW 180 Life Sciences Corp.
0.0077
0.00%
GOVXW GeoVax Labs, Inc.
0.0300
-0.33%
MSCLF Satellos Bioscience Inc.
0.5020
0.00%
KTTAW Pasithea Therapeutics Corp.
0.0166
-2.35%
AGNPF Algernon Pharmaceuticals Inc.
0.0520
0.00%